Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

A Review of Pharmacologic Management and Prevention Strategies for Delirium in the Intensive Care Unit
Jozef Bledowski, M.D.; Alex Trutia, M.D.
FOCUS 2013;11:568-575. doi:10.1176/appi.focus.11.4.568

Background  The prevalence of delirium has been estimated at anywhere between 10% and 30% in general medical patients and in upwards of 80% in patients who are admitted to an intensive care unit (ICU). Given the high prevalence of delirium in the ICU population, it should not be surprising that a large percentage of psychiatric consults arise from this setting. While the mainstay of pharmacologic management of delirium centers on neuroleptic medications, such as haloperidol, recent studies using alternate agents have shown varying levels of promise.

Objective  Our purpose is to outline the major prospective studies looking at the efficacy of pharmacologic management and prevention strategies for delirium exclusively in adult ICU patients. Both conventional and novel pharmacotherapeutic interventions are discussed.

Method  Articles were obtained using the MEDLINE/PUBMED database looking specifically at pharmacologic interventions for delirium in the intensive care unit. A search was performed using the key words-“delirium,” “intensive care unit,” “treatment,” and “prophylaxis.” The authors limited their search to prospective studies, specifically randomized trials (both placebo-controlled and non-controlled) in the adult ICU population, and eliminated retrospective and observational studies. Relevant citations from the previously mentioned articles were also included in the review.

Conclusion  There is a plethora of studies on pharmacologic management strategies in general medical patients with delirium. Findings from these studies are often extrapolated to the ICU population; however, when looking at studies limited to ICU patients with delirium, there are far fewer credible prospective studies.
(Reprinted with permission from Psychosomatics, 2012; 53:203–211) 

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Anchor for Jump
Table 1.Major Randomized Trials of Pharmacotherapeutic Interventions for Delirium in the ICU Population


Ely  EW;  Shintani  A;  Truman  B;  Speroff  T;  Gordon  SM;  Harrell  FE  Jr.  et al:  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.  JAMA 2004; 291(14):1753–1762
[CrossRef] | [PubMed]
Heymann  A;  Radtke  F;  Schiemann  A;  Lütz  A;  MacGuill  M;  Wernecke  KD  et al:  Delayed treatment of delirium increases mortality rate in intensive care unit patients.  J Int Med Res 2010; 38(5):1584–1595
[CrossRef] | [PubMed]
Hshieh  TT;  Fong  TG;  Marcantonio  ER;  Inouye  SK:  Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence.  J Gerontol A Biol Sci Med Sci 2008; 63(7):764–772
[CrossRef] | [PubMed]
Schetz  JA;  Perez  E;  Liu  R;  Chen  S;  Lee  I;  Simpkins  JW:  A prototypical σ-l receptor antagonist protects against brain ischemia.  Brain Res 2007; 1181:1–9
[CrossRef] | [PubMed]
Song  C;  Lin  A;  Kenis  G;  Bosmans  E;  Maes  M:  Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist.  Schizophr Res 2000; 42(2):157–164
[CrossRef] | [PubMed]
Jacobi  J;  Fraser  GL;  Coursin  DB;  Riker  RR;  Fontaine  D;  Wittbrodt  ET  et al: Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians.  Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.  Crit Care Med 2002; 30(1):l19–141; Erratum in: Crit Care Med 2002; 30(3):726
Riker  RR;  Fraser  GL;  Cox  PM:  Continuous infusion of haloperidol controls agitation in critically ill patients.  Crit Care Med 1994; 22(3):433–440
[CrossRef] | [PubMed]
Seneff  MG;  Mathews  RA:  Use of haloperidol infusions to control delirium in critically ill adults.  Ann Pharmacother 1995; 29(7/8):690–693
Menza  MA;  Murray  GB;  Holmes  VF;  Rafuls  WA:  Decreased extrapyramidal symptoms with intravenous haloperidol.  J Clin Psychiatry 1987; 48(7):278–280
Glassman  AH;  Bigger  JT  Jr.:  Antipsychotic drugs: Prolonged QTc interval, torsades de pointes, and sudden death.  Am J Psychiatry 2001; 158(11):1774–1782
[CrossRef] | [PubMed]
Lonergan  E;  Britton  AM;  Luxenberg  J;  Wyller  T:  Antipsychotics for delirium.  Cochrane Database Syst Rev 2007; 2:CD005594. Review
Rea  RS;  Battistone  S;  Fong  JJ;  Devlin  JW:  Atypical antipsychotics vs. haloperidol for treatment of delirium in acutely ill patients.  Pharmacotherapy 2007; 27(4):588–594
[CrossRef] | [PubMed]
Han  C;  Kim  Y:  A double-blind trial of risperidone and haloperidol for the treatment of delirium.  Psychosomatics 2004; 45(4):297–301
[CrossRef] | [PubMed]
Skrobik  YK;  Bergeron  N;  Dumont  M;  Gottfried  SB:  Olanzapine vs. haloperidol: treating delirium in a critical care setting.  Intensive Care Med 2004; 30(3):444–449
[CrossRef] | [PubMed]
Girard  TD;  Pandharipande  PP;  Carson  SS;  Schmidt  GA;  Wright  PE;  Canonico  AE  et al: MIND Trial Investigators.  Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.  Crit Care Med 2010; 38(2):428–437
[CrossRef] | [PubMed]
Balas  MC.  Free your MIND and the rest will follow: decoding delirium in the intensive care unit.  Crit Care Med 2010; 38(2):697–698
[CrossRef] | [PubMed]
Devlin  JW;  Roberts  RJ;  Fong  JJ;  Skrobik  Y;  Riker  RR;  Hill  NS  et al:  Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.  Crit Care Med 2010; 38(2):419–427
[CrossRef] | [PubMed]
van Eijk  MM;  Roes  KC;  Honing  ML;  Kuiper  MA;  Karakus  A;  van der Jagt  M  et al:  Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicenter, double-blind, placebo-controlled randomised trial.  Lancet 2010; 376(9755):1829–1837
[CrossRef] | [PubMed]
Aantaa  R;  Jalonen  J:  Perioperative use of α-2 adrenoceptor agonists and the cardiac patient.  Eur J Anaesthesiol 2006; 23(5):361–372
[CrossRef] | [PubMed]
Huang  R;  Chen  Y;  Yu  AC;  Hertz  L:  Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its neuroprotective activity.  J Cereb Blood Flow Metab 2000; 20(6):895–898
[CrossRef] | [PubMed]
Gertler  R;  Brown  HC;  Mitchell  DH;  Silvius  EN:  Dexmedetomidine: a novel sedative-analgesic agent.  Proc (Bayl Univ Med Cent) 2001; 14(1):13–21
Guinter  JR;  Kristeller  JL.  Prolonged infusions of dexmedetomidine in critically ill patients.  Am J Health-Syst Pharm 2010; 67:1246–1253
[CrossRef] | [PubMed]
Gerlach  AT;  Murphy  CV;  Dasta  JF:  An updated focused review of dexmedetomidine in adults.  Ann Pharmacother 2009; 43(12):2064–2074
Pandharipande  PP;  Pun  BT;  Herr  DL;  Maze  M;  Girard  TD;  Miller  RR  et al:  Effect of sedation with dexmedetomidine vs. lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.  JAMA 2007; 298(22):2644–2653
[CrossRef] | [PubMed]
Riker  RR;  Shehabi  Y;  Bokesch  PM;  Ceraso  D;  Wisemandle  W;  Koura  F  et al:  SEDCOM (Safety and Efficacy of Dexmedetomidine Compared with Midazolam) Study Group. Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial.  JAMA 2009; 301(5):489–499
[CrossRef] | [PubMed]
Ruokonen  E;  Parviainen  I;  Jakob  SM;  Nunes  S;  Kaukonen  M;  Shepherd  ST  et al:  “Dexmedetomidine for Continuous Sedation” Investigators. Dexmedetomidine vs. propofol/midazolam for long-term sedation during mechanical ventilation.  Intensive Care Med 2009; 35(2):282–290
[CrossRef] | [PubMed]
Reade  MC;  O’Sullivan  K;  Bates  S;  Goldsmith  D;  Ainslie  WR;  Bellomo  R:  Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomized open-label trial.  Crit Care 2009; 13(3):R75
Aho  M;  Lehtinen  AM;  Erkola  O;  Kallio  A;  Korttila  K:  The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy.  Anesthesiology 1991; 74(6):997–1002
[CrossRef] | [PubMed]
Buttermann  AE;  Reid  K;  Maze  M.  Are cholinergic pathways involved in the anesthetic response to α-2 agonists.  Toxicol Lett 1998; 100/101:17–22
Hsu  YW;  Cortinez  LI;  Robertson  KM;  Keifer  JC;  Sum-Ping  ST;  Moretti  EW  et al:  Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers.  Anesthesiology 2004; 101(5):1066–1076
[CrossRef] | [PubMed]
Maldonado  JR;  Wysong  A;  van der Starre  PJ;  Block  T;  Miller  C;  Reitz  BA:  Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery.  Psychosomatics 2009; 50(3):206–217
[CrossRef] | [PubMed]
Nelson  LE;  Lu  J;  Guo  T;  Saper  CB;  Franks  NP;  Maze  M.  The α-2 adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.  Anesthesiology 2003; 98(2):428–436
[CrossRef] | [PubMed]
Weinbroum  AA;  Ben-Abraham  R:  Dextromethorphan and dexmedetomidine: new agents for the control of perioperative pain.  Eur J Surg 2001; 167(8):563–569
[CrossRef] | [PubMed]
Pandharipande  P;  Shintani  A;  Peterson  J;  Pun  BT;  Wilkinson  GR;  Dittus  RS  et al:  Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients.  Anesthesiology 2006; 104(1):21–26
[CrossRef] | [PubMed]
Dasta  JF;  Kane-Gill  SL;  Pencina  M;  Shehabi  Y;  Bokesch  P;  Wisemandle  W  et al:  A cost minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit.  Crit Care Med 2010; 38(2):497–503
[CrossRef] | [PubMed]
Prakanrattana  U;  Prapaitrakool  S.  Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery.  Anaesth Intensive Care 2007; 35(5):714–719
Hudetz  JA;  Patterson  KM;  Iqbal  Z;  Ganhi  SD;  Byrne  AJ;  Hudetz  AG  et al:  Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass.  J Cardiothorac Vase Anesth 2009; 23(5):651–657
Gamberini  M;  Bolliger  D;  Lurati Buse  GA;  Burkhart  CS;  Grapow  M;  Gagneux  A  et al:  Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery—a randomized controlled trial.  Crit Care Med 2009; 37(5):1762–1768
[CrossRef] | [PubMed]
Shehabi  Y;  Grant  P;  Wolfenden  H;  Hammond  N;  Bass  F;  Camp bell  M  et al:  Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study).  Anesthesiology 2009; 111(5):1075–1084
[CrossRef] | [PubMed]
Rubino  AS;  Onorati  F;  Caroleo  S;  Galato  E;  Nucera  S;  Amantea  B  et al:  Impact of clonidine administration on delirium and related respiratory weaning after surgical correction of acute type-A aortic dissection: results of a pilot study.  Interact Cardiovasc Thorac Surg 2010; 10(l):58–62
[CrossRef] | [PubMed]
Pandharipande  P;  Sanders  RD;  Girard  TD;  McGrane  S;  Thompson  JL;  Shintani  AK  et al,  MENDS investigators: Effect of dexmedetomidine vs. lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.  Crit Care 2010; 14(2):R38
References Container

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 62.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 25.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 25.  >
Textbook of Traumatic Brain Injury, 2nd Edition > Chapter 35.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 10.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles